PF
Patrick Flaherty
Principal Investigator
Duquesne University
I'm working on
8 months ago
Medicinal chemistry, kinase signaling, antivirals, oncology, neurodegeneration
About
Patrick Flaherty develops small‑molecule therapeutics across oncology, antivirals and neurodegeneration. He holds 3 issued patents and leads design on grants targeting MEK5/ERK5 and SARS‑CoV‑2 RdRp at Duquesne in collaboration with University of Pittsburgh.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.